US DOT COVID-19 Guidance for Drug and Alcohol Testing Requirements

PMAA

The U.S. DOT has issued guidance for employers who may have difficulty conducting mandated federal drug and alcohol testing due the recent COVID-19 outbreak. Barriers to testing include unavailability of collection sites, breath alcohol technicians (BAT), medical review officers (MRO) and substance abuse professionals (SAP) caused by the COVID-19 outbreak. The guidance provides employers with testing flexibility by recognizing COVID-19 as a possible barrier to testing. In some cases, missed tests must take place at a later date according to the guidance.

WARNING! This is not a blanket waiver of U.S. DOT drug and alcohol testing requirements. Employers must follow existing regulations requiring a detailed written explanation on why testing could not be conducted or delayed until a later date and the reasonable efforts taken to find alternative testing venues. Moreover, in no case can an employee, including drivers, conduct safety sensitive functions without first obtaining a negative pre-employment test for drugs and a negative return-to-duty test for drug and alcohol. PLEASE CLICK HERE FOR FULL ARTICLE